Lesion Absorbed Dose–Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy

前列腺癌 医学 病变 核医学 癌症 前列腺 阉割 泌尿科 肿瘤科 放射科 内科学 病理 激素
作者
Milan Grkovski,Simone Krebs,Joseph A. O’Donoghue,Jonathan Kuten,Audrey Mauguen,Parnian Shobeiri,Daniel Lafontaine,Maria Thor,Finn Augensen,Josef J. Fox,Neeta Pandit‐Taskar,Mark Dunphy,Lisa Bodei,John L. Humm,Heiko Schöder
出处
期刊:The Journal of Nuclear Medicine [Society of Nuclear Medicine and Molecular Imaging]
卷期号:: jnumed.125.270170-jnumed.125.270170
标识
DOI:10.2967/jnumed.125.270170
摘要

The relationship between lesion absorbed dose (AD) and response in patients with metastatic castration-resistant prostate cancer undergoing [177Lu]Lu-PSMA-617 radiopharmaceutical therapy (RPT) remains poorly understood. The objective of this work was to investigate the AD-response relationship at both the patient and lesion levels. Methods: Sixty-five patients underwent serial SPECT/CT imaging after receiving 7.31 ± 0.27 GBq of [177Lu]Lu-PSMA-617. Single-time-point (STP) (Hänscheid approximation at 72 h) and multiple-time-point voxelwise dosimetry were performed. Patient response was evaluated by changes in serum prostate-specific antigen level before and after cycle 1 of RPT. The response of individual lesions was evaluated by the change in the SUVmax before, during, and after RPT with [68Ga]Ga-PSMA-11 PET/CT. Results: Baseline PET and SPECT lesion SUVmax were strongly correlated (Pearson r, 0.74; n = 1364 lesions). Kidney ADs were relatively low (0.28 ± 0.12 Gy/GBq). No significant decrease in estimated glomerular filtration rate was observed 1 y after RPT. On average, STP dosimetry underestimated the AD by 8%. A moderate negative relationship was observed between the mean lesion AD for an individual patient (Spearman ρ, -0.33; n = 63) and lesion (Spearman ρ, -0.30; n = 681) responses. Patients receiving a higher mean AD (>7.5 Gy) had a significantly better prostate-specific antigen response (median, 70% vs. -5%; P < 0.001; unpaired t test) and longer biochemical progression-free survival (median, 4.1 mo vs. 1.6 mo; P = 0.005; unpaired t test) compared with patients whose mean AD was less than 7.5 Gy, respectively. Conclusion: A moderate AD-response relationship was observed in patients with metastatic castration-resistant prostate cancer undergoing [177Lu]Lu-PSMA-617 RPT. The feasibility of STP dosimetry facilitates its implementation for treatment personalization. Kidney ADs may be reduced with abundant hydration.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
初景的应助被yyc采纳,获得50
1秒前
博修发布了新的文献求助10
1秒前
1秒前
2秒前
大胆乐儿完成签到,获得积分10
3秒前
舒适飞薇完成签到,获得积分20
3秒前
斯文网络完成签到,获得积分10
3秒前
天真芷天发布了新的文献求助10
3秒前
标致土豆发布了新的文献求助10
3秒前
万能图书馆的应助被小王采纳,获得10
3秒前
崔伟完成签到,获得积分10
3秒前
嘻嘻哈哈的应助被gaoyingxin采纳,获得10
4秒前
4秒前
4秒前
Zz完成签到,获得积分10
4秒前
在水一方的应助被科研通管家采纳,获得10
4秒前
852的应助被xu采纳,获得10
4秒前
123发布了新的文献求助10
4秒前
传奇3的应助被科研通管家采纳,获得10
5秒前
慕青的应助被科研通管家采纳,获得10
5秒前
所所的应助被科研通管家采纳,获得10
5秒前
爆米花的应助被科研通管家采纳,获得10
5秒前
天天向上的应助被科研通管家采纳,获得10
5秒前
桐桐的应助被科研通管家采纳,获得10
5秒前
Maestro_S的应助被科研通管家采纳,获得10
5秒前
5秒前
充电宝的应助被科研通管家采纳,获得10
6秒前
无极微光的应助被科研通管家采纳,获得20
6秒前
CodeCraft的应助被科研通管家采纳,获得10
6秒前
orixero的应助被科研通管家采纳,获得10
6秒前
斯文网络发布了新的文献求助10
6秒前
6秒前
6秒前
Maestro_S的应助被科研通管家采纳,获得10
6秒前
Owen的应助被科研通管家采纳,获得10
6秒前
6秒前
PIUPIU1003的应助被科研通管家采纳,获得10
7秒前
FashionBoy的应助被科研通管家采纳,获得10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186261
求助须知:如何正确求助?哪些是违规求助? 9574697
关于积分的说明 21837731
捐赠科研通 7783915
什么是DOI,文献DOI怎么找? 3434752
关于科研通互助平台的介绍 2559109
邀请新用户注册赠送积分活动 2481528